Position in NBIX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$164,675,000
+$160,904,300 QoQ
Shares Held
1,250,000
+4066.7% QoQ
Ownership
1.24%
of shares outstanding
% of Portfolio
4.60%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
4 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Vestal Point Capital, LP holds $276,026,500 across 3 Drug Manufacturers - Specialty & Generic names. NBIX ranks #1 (59.7% of the industry book) .
All Filings in NBIX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $164,675,000 | 1,250,000 | Shares | Sole | 2026-05-15 | |
| 2025-06-30 | $3,770,700 | 30,000 | Shares | Sole | 2025-08-14 | |
| 2024-03-31 | $97,923,200 | 710,000 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $105,408,000 | 800,000 | Shares | Sole | 2024-02-13 | |
| No filing history on record for this holder in this stock. | ||||||